Cognitive dysfunction

Cognitive dysfunction or cognitive impairment is a symptom in most diagnostic criteria for ME/CFS; some patients call it "brain fog". It is also a common symptom of fibromyalgia which many patients call "fibro fog."

Forms of cognitive dysfunction commonly found in ME/CFS include reduced attention span, auditory sequencing problems, brain fog, cognitive overload, concentration problems, confusion, difficulty comprehending social cues, difficulties with calculations, dyslexia, executive function problems, linguistics reversals, multi-tasking problems, planning problems, poor working memory, receptive language problems, short-term memory problems, slowed thought, spatial disorientation, slow processing of information and word-finding problems. A 2016 study found that IQ scores of adolescents with CFS tested lower than the IQ scores of healthy peers with an equivalent school level. Currently it is not known whether lower IQ outcomes are due to concentration problems, a lowered processing speed or the illness itself.

Symptom recognition
Cognitive dysfunction is a particularly common symptom of ME/CFS, but is also a symptom of many other illnesses.

Mandatory ME/CFS symptom
Cognitive dysfunction is a mandatory diagnostic symptom for ME/CFS with the Canadian Consensus Criteria (CCC).

Optional ME/CFS symptom
Impaired memory or ability to concentrate is a core symptom in the current CDC ME/CFS diagnostic criteria diagnostic criteria, and is required when orthostatic intolerance is not present. Cognitive dysfunction is part of the possible diagnostic symptoms in the International Consensus Criteria (ICC) for myalgic encephalomyelitis (ME).

Diagnosis

 * Cognitive Dysfunction and “Brain Fog” in POTS

Cerebrospinal fluid changes
Mady Hornig and colleagues have found evidence in the cerebrospinal fluid (CSF) of ME/CFS patients that may explain their cognitive dysfunction.

Brain changes


Zinn et al. (2016) studied brain functioning in chronic fatigue syndrome and concluded: "Our case study confirmed the pattern of dysregulation in the cortex reviewed in the introduction. Furthermore, since both periods of phase shift/lock durations were found to be significantly shorter, that might contribute to an increased rate of phase reset, also seen in our data. Phase reset deregulation--phase locking periods being too brief and phase reset happening too often—appear to be consistent with the associated lower rate of information processing and reaction times found in the ME and CFS literature. These deregulated states represent the brain during nonoptimal functioning, rendering it inefficient for most types of information processing functioning, whether it is executive functioning, memory, perceptual reasoning or information processing speed. When phase lock is significantly less than normal, as in this data set, the ability of the brain to sustain commitment of resources to mediate different functions is severely compromised. Phase shift duration in this data is also hypoactive, meaning that significantly less neurons are being recruited to perform a function than normal. The results here indicate slowed verbal comprehension, executive functions, perceptual reasoning, processing speed and memory, the sum total of which is known as cognitive impairment."

Drug and supplements
Drugs, supplements or treatment interventions that may cause cognitive problems in some ME/CFS patients:
 * Diphenhydramine (Benadryl) an antihistamine also used to aid sleep
 * Certain pain killers, particularly opioids, gabapentin (Neurontin), tricyclic antidepressants including amitriptyline (Elavil, Endep) and nortriptyline (Aventyl, Pamelor)
 * sleep medications

Exercise and graded exercise therapy
A healthy person becomes more alert after exercise, but people with ME/CFS find their cognitive difficulties increase, they become much slower at mental activities, and cognitive tasks seem to take extra effort. Graded exercise therapy (GET) / Graded Activity Therapy also has this effect in ME/CFS patients.

Other illnesses or health conditions
Cognitive dysfunction can be caused or made worse by other health conditions, most of which should be ruled out or identified during diagnostic process for ME/CFS:
 * Cancer or cancer treatment ("chemo brain")
 * Depression
 * Fibromyalgia
 * Long COVID symptoms
 * Lupus
 * Menopause
 * Multiple sclerosis
 * Pregnancy
 * Sleep dysfunction or sleep disorders

Potential treatments
Drugs, supplements and other treatments that have been suggested for reducing cognitive impairment and/or improving brain fog include:
 * Acetyl-L-carnitine
 * Arabinoxylan (ineffective)
 * B vitamin complex
 * B vitamin
 * Clonidine hydrochloride (ineffective)
 * Dexamphetamine
 * Dynamic Neural Retraining System
 * Fludrocortisone (ineffective)
 * Histamine
 * Hydrocortisone (most trials show some positive effective)
 * Methylene blue
 * Methylphenidate and the experimental treatment KPAX002
 * Modafinil (ineffective)
 * Moclobemide
 * Neurolinguistic programming
 * Nimodipine
 * Phenelzine (ineffective in ME/CFS)
 * Rintatolimod (Ampligen)
 * Stellate ganglion block in dysautonomia in some long COVID patients
 * Valganciclovir (ineffective)
 * Yoga

Notable studies

 * 2022, Systematic review and meta‐analysis of cognitive impairment in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) - (Full text)
 * 2016, Cognitive Dysfunction in Chronic Fatigue Syndrome: a Review of Recent Evidence - (Abstract)
 * 2016, The impact of chronic fatigue syndrome on cognitive functioning in adolescents - (Full text)
 * 2016, qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report - (Full text)
 * 2011, Cognitive deficits in patients with chronic fatigue syndrome compared to those with major depressive disorder and healthy controls - (Full text)
 * 2006, Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome - (Full text)
 * 2015, Less efficient and costly processes of frontal cortex in childhood chronic fatigue syndrome - (Full Text)
 * 2001, Neuropsychological functioning in chronic fatigue syndrome: a review - (Abstract)

Disability
In 2018 Brian Vastag was able to prove the severity of his chronic fatigue syndrome cognitive dysfunction with qEEG and cognitive tests, which proved he had "significant problems with visual perception and analysis, scanning speed, attention, visual motor coordination, motor and mental speed, memory, and verbal fluency" winning his long term disability (LTD) claim in the United States.

Learn more

 * 2015, Dr. Gudrun Lange Reviews Neuropsychological Testing for CFS and FM
 * 2016, Case Study: "Brain Fog" in CFS can be seen in qEEG/Loreta
 * 2018, Study Identifies the Types of Cognitive Dysfunction That Are Most Prevalent in Fibromyalgia
 * Jun 4, 2018, Victory For ME Disability Claim – U.S. Court Upholds Plaintiff's Lawsuit After Being Denied Disability